Trends in Upper Gastrointestinal Bleeding in Children: The Impact of Helicobacter pylori Infection and Non-Steroidal Anti-Inflammatory Drug Use
- PMID: 39200052
- PMCID: PMC11350693
- DOI: 10.3390/antibiotics13080752
Trends in Upper Gastrointestinal Bleeding in Children: The Impact of Helicobacter pylori Infection and Non-Steroidal Anti-Inflammatory Drug Use
Abstract
Upper gastrointestinal bleeding (UGIB) is a significant concern in children, contributing to 6-20% of cases in pediatric intensive care units. This study evaluates the roles of Helicobacter pylori (H. pylori) infection and non-steroidal anti-inflammatory drug (NSAID) usage in the etiology of UGIB in children, with a particular focus on trends observed during the COVID-19 pandemic. We conducted a retrospective analysis of 103 pediatric patients who underwent esophagogastroduodenoscopy (EGD) for UGIB between January 2015 and December 2023. Of these, 88 patients were included in the final analysis, where the source of bleeding was successfully identified. Hematemesis was the most common presentation, and the source of bleeding was identified in 85.43% of cases. The prevalence of H. pylori infection remained stable across the pre-pandemic (39.7%) and post-pandemic (36.7%) periods. However, NSAID usage increased nearly threefold during the pandemic, with 36.7% of post-pandemic UGIB cases associated with NSAID use, compared to 12.1% pre-pandemic. These findings underscore the significant roles of H. pylori and NSAID use in pediatric UGIB, with a notable increase in NSAID-related cases during the pandemic.
Keywords: COVID-19 pandemic; Helicobacter pylori infection; children; esophagogastroduodenoscopy; hematemesis; hematochezia; melena; non-steroidal anti-inflammatory drugs; upper gastrointestinal bleeding.
Conflict of interest statement
The authors declare no conflicts of interest.
Figures


Similar articles
-
Helicobacter pylori and bleeding duodenal ulcer: prevalence of the infection and role of non-steroidal anti-inflammatory drugs.Scand J Gastroenterol. 2001 Jul;36(7):717-24. doi: 10.1080/003655201300191978. Scand J Gastroenterol. 2001. PMID: 11444470
-
The effect of non-steroidal anti-inflammatory drugs and Helicobacter pylori infection on the gastric mucosa in children with upper gastrointestinal bleeding.Pediatr Surg Int. 2010 Feb;26(2):227-30. doi: 10.1007/s00383-009-2492-x. Epub 2009 Oct 13. Pediatr Surg Int. 2010. PMID: 19823852
-
Upper Gastrointestinal Bleeding in Children: The Role of Helicobacter pylori Infection and Non-steroidal Anti-inflammatory Drug Use.West Indian Med J. 2015 Mar;64(2):113-6. doi: 10.7727/wimj.2014.130. Epub 2015 Jan 29. West Indian Med J. 2015. PMID: 26360683 Free PMC article.
-
Systematic reviews of the clinical effectiveness and cost-effectiveness of proton pump inhibitors in acute upper gastrointestinal bleeding.Health Technol Assess. 2007 Dec;11(51):iii-iv, 1-164. doi: 10.3310/hta11510. Health Technol Assess. 2007. PMID: 18021578 Review.
-
Interaction or relationship between Helicobacter pylori and non-steroidal anti-inflammatory drugs in upper gastrointestinal diseases.World J Gastroenterol. 2006 Jun 28;12(24):3789-92. doi: 10.3748/wjg.v12.i24.3789. World J Gastroenterol. 2006. PMID: 16804960 Free PMC article. Review.
Cited by
-
New perspectives for optimizing fever and pain management in pediatrics: evidence supporting therapeutic awareness in clinical practice.Ital J Pediatr. 2025 Aug 15;51(1):255. doi: 10.1186/s13052-025-02107-3. Ital J Pediatr. 2025. PMID: 40817220 Free PMC article. Review.
References
-
- Thomson M., Tringali A., Landi R., Dumonceau J.M., Tavares M., Amil-Dias J., Benninga M., Tabbers M.M., Furlano R., Spaander M., et al. Pediatric Gastrointestinal Endoscopy: European Society of Pediatric Gastroenterology Hepatology and Nutrition (ESPGHAN) and European Society of Gastrointestinal Endoscopy (ESGE) Guidelines. J. Pediatr. Gastroenterol. Nutr. 2017;64:133–153. doi: 10.1097/MPG.0000000000001408. - DOI - PubMed
-
- Galoș F., Boboc C., Ieșanu M.-I., Anghel M., Ioan A., Iana E., Coșoreanu M.T., Boboc A.A. Antibiotic Resistance and Therapeutic Efficacy of Helicobacter Pylori Infection in Pediatric Patients—A Tertiary Center Experience. Antibiotics. 2023;12:146. doi: 10.3390/antibiotics12010146. - DOI - PMC - PubMed
-
- Nguyen T.C., Tang N.L.C., Le G.K.N., Nguyen V.T., Nguyen K.H.G., Che T.H., Phan V.T.T., Nguyen N.M., Truong D.Q., Ngo X.M., et al. Helicobacter Pylori Infection and Peptic Ulcer Disease in Symptomatic Children in Southern Vietnam: A Prospective Multicenter Study. Healthcare. 2023;11:1658. doi: 10.3390/healthcare11111658. - DOI - PMC - PubMed
LinkOut - more resources
Full Text Sources